Diffusion Pharmaceuticals Inc. (NASDAQ:DFFN) Recent Earnings Shows Major Promise

Diffusion Pharmaceuticals Inc. (NASDAQ:DFFN) Recent Earnings Shows Major Promise


The Diffusion Pharmaceuticals Inc. (DFFN) shares are trading at higher $1.19.

To add more color to this target, the company’s high over the last year is $2.42 and the low is $0.21. Over the last 52 weeks, DFFN is down -50.83% while the S&P 500 is down -0.36%. The catalyst for this interesting swing was the company’s recent earnings report.

A Notable Earnings Report

In the last quarter, DFFN reported a profit of $34000.0. Diffusion Pharmaceuticals Inc. also saw revenues decrease to $2.96 million. In addition, DFFN has free cash flow of -$3.5 million as of 03-2020. The company’s EBITDA came in at -$2.93 million which compares well with its peers.

DFFN Return on Equity (ROE) is -68.60%, and its Return on Assets is -57.80%. All told, it is clear that, DFFN needs to be on your watchlist.

Find out when DFFN reaches critical levels. Subscribe to OracleDispatch.com Right Now by entering your Email in the box below.

Of course, we must look beyond the financials and question how well those numbers represent the sustainable earnings power of the business. Investors need to know how sustainable this current run. DFFN has a short ratio of 0.08 and outstanding shares of 59.63M.

Company Outlook

DFFN has seen increased volume after this news and investors are putting their support behind the value proposition. Furthermore, 10-day volume stands at 5.64 million and more growth is possible in the weeks ahead. Traders will also note the company’s earnings per share came in at -1.56. Diffusion Pharmaceuticals Inc. DFFN also noted assets of $21.06 million at the end of the last quarter. Investors should also keep an eye on sector updates as DFFN has historically followed its peers on positive news.

All told, Diffusion Pharmaceuticals Inc. DFFN has strung together solid data and demonstrated underlying fundamentals. At its current valuation, DFFN represents an interesting risk/reward case. Traders should stay tuned to see if this recent report will push the stock to test recent resistance levels.

Diffusion Pharmaceuticals Inc. DFFN is now commanding a market cap of 70.95M and a float of 45.86M. DFFN is increasing its credibility in this sector and that could lead to more upside down the line. Sign-up for continuing coverage on shares of DFFN stock, as well as other hot stock picks, get our free newsletter today and get our next breakout pick!

Disclosure: we hold no position in DFFN, either long or short, and we have not been compensated for this article.